Fortress Biotech (FBIO) Misses Q3 EPS by 72c

Fortress Biotech (NASDAQ: FBIO) reported Q3 EPS of ($0.94), $0.72 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $34.75 million versus the consensus estimate of $14.28 million.

For earnings history and earnings-related data on Fortress Biotech (FBIO) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• JPMorgan Downgrades Rakuten Inc. (4755:JP) (RKUNF) to Neutral
• Disney initiated at Buy as analyst sees parks, streaming fueling next growth phase